跳至主要内容
临床试验/NCT00595621
NCT00595621已完成不适用

Multi-Channel Gastric Electrical Stimulation for the Treatment of Gastroparesis

University of Kansas Medical Center2 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2006年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
22
试验地点
2
主要终点
Percentage of Slow Wave Entrainment

研究概览

简要总结

Investigate the safety and efficacy of multi-channel gastric electrical stimulation in the treatment of patients with severe diabetic gastroparesis refractory to standard therapy.

详细描述

Evaluation of severe symptom control of nausea, vomiting, postprandial fullness, early satiety, bloating and discomfort related to drug refractory gastroparesis present as a GI complication in diabetic patients. External gastric pacemaker system will be placed at the same time of implantation of Enterra (internal gastric stimulator-permanent device) to assess symptoms, quality of life improvement and investigate the changes in gastric emptying time in diabetic gastroparesis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Severe nausea and vomiting for at least 6 months
  • Documented delayed gastric emptying
  • Failed extensive medical treatment

排除标准

  • Previous gastric surgery
  • Pregnancy or planned pregnancy
  • Primary eating or swallowing disorders
  • Scheduled or planned MRI testing

结局指标

主要结局

Percentage of Slow Wave Entrainment

时间窗: 12 Weeks

Participants were monitored for up to 3 months. Measure is the percent of normal slow waves (2-4 cpm) generated by MGP-1 device while it was ON or OFF

次要结局

  • The Percent (Percentage) of Gastric Retention of a Solid Meal(12 Weeks)
  • Changes in Quality of Life (QoL) Assessment (Physical (P) and Mental (M))(12 Weeks)
  • Severity of Gastroparetic Symptoms(12 weeks)
  • Changes in Hemoglobin A1c (HbA1c) Level(12 Weeks)
  • Changes in Hospital Admissions(12 Weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验